CORVUS PHARMACEUTICALS INC (CRVS) — insider trading
Health Care · NASDAQ
CORVUS PHARMACEUTICALS INC (CRVS) has 38 reported SEC Form 4 insider transactions in our data, including 3 open-market purchases among the most recent 38 (latest 2026-06-11).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-11 | van den Broek Richard | Director | Grant / award / vesting (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-06-11 | Thompson Peter A. | Director, 10% owner | Grant / award / vesting (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-06-11 | Grais Linda | Director | Grant / award / vesting (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-06-11 | CLARK IAN T | Director | Grant / award / vesting (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-06-11 | Moore David Scott | Director | Grant / award / vesting (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-06-11 | Moore David Scott | Director | Open-market purchase | 21,700 | $11.53 | $250.2K | Form 4 |
| 2026-05-18 | MILLER RICHARD A MD | Director, Officer (President and CEO) | Open-market purchase | 1,932 | $12.01 | $23.2K | Form 4 |
| 2026-05-18 | MILLER RICHARD A MD | Director, Officer (President and CEO) | Open-market purchase | 5,000 | $12.05 | $60.3K | Form 4 |
| 2026-04-23 | Chan Andrew C. | Director | Grant / award / vesting (derivative) | 30,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion (derivative) | 30,000 | $0.00 | $0 | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 15,000 | $2.12 | $31.8K | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 15,000 | $1.64 | $24.6K | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 15,000 | $2.49 | $37.4K | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 15,000 | $0.97 | $14.5K | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 15,000 | $0.99 | $14.8K | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 15,000 | $2.60 | $39.0K | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 15,000 | $2.74 | $41.1K | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 15,000 | $3.27 | $49.0K | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 15,000 | $2.00 | $30.0K | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 15,000 | $3.61 | $54.1K | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 15,000 | $12.50 | $187.5K | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 15,000 | $9.70 | $145.5K | Form 4 |
| 2026-01-28 | Thompson Peter A. | Director, 10% owner | Option exercise / conversion | 30,000 | $15.00 | $450.0K | Form 4 |
| 2025-12-04 | Arcara Jeffrey | Officer (Chief Business Officer) | Grant / award / vesting (derivative) | 100,000 | $0.00 | $0 | Form 4 |
| 2025-12-04 | MILLER RICHARD A MD | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 1,000,000 | $0.00 | $0 | Form 4 |
| 2025-12-04 | Jones William Benton | Officer (See Remarks) | Grant / award / vesting (derivative) | 400,000 | $0.00 | $0 | Form 4 |
Ask the chat about CRVS's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CORVUS PHARMACEUTICALS INC (CRVS).
Last updated 2026-06-11 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.